Background/Aims: miR221 might have an important role in human embryo development. However, little is known about the function of miR221 in the human embryo. The aim of this study was to evaluate miR221 expression in human placental tissue, and to analyze the relationship between miR221 and target genes. Methods: The human placentas tissue samples were collected from healthy pregnant women who were willing to terminate their pregnancy. The total RNA isolation and microRNA reverse transcription quantification were performed by TaqMan microRNA assay and qRT-PCR. Results: The results showed that miR221 expression was significantly higher in 55-to 71-day placenta (mean value=0.1049) than that in 38-to 54-day (the mean value=0.0133) (p<0.001). miR221 targeting genes, such as PIK3R1, CDKN1B, CDKN1C, DDIT4, and FOS, were detected in human placenta tissue, but only DDIT4 was significantly decreased with development (mean value: 0.0101 for 38~54 days, 0.0021 for 55~71 days, p<0.001). Further analysis showed that only DDIT4 was negatively correlated with miR221 expression p=0.033; PI3KR: r=0.322, p=0.089; CDKN1B: r=0.298, p=0.128; CDKN1C: r=0.198, p=0.304; FOS: r=0.171, p=0.347). Conclusion: These findings indicate that miR221 might play an important role in human placental development by precisely regulating the DDIT4 expression.
Introduction
MicroRNAs (miRNAs) are about 22-nucleotides, short, noncoding RNAs, which serve as an important regulator of protein levels by binding to 3'UTRs of target mRNAs and either inhibiting translation or inducing mRNA degradation [1] [2] [3] [4] [5] . miRNA is detected in all organisms and regulated stability or translation of 20~30% of all mRNAs in vertebrate [6] [7] [8] [9] . Thus, miRNAs are important in different stages and processes of embryonic development, such as cell differentiation, proliferation, and organ formation [10, 11] . miR-221 is located at the X-chromosome and has 23 nucleotides. Previous reports suggest that miR-221 plays an important role in development and growth. It is expressed in neurons and/or cranial ganglia in forebrain and midbrain, as well as rhombomere in zebrafish embryo [12] , suggesting its potential roles in brain development. Moreover, miR221 is observed to be down-regulated during differentiation of hematopoietic progenitor cells, which facilitates normal erythropoiesis and erythroleukemic cell growth via unblocking KIT protein production [13] . However, miR221 over-expression in the mouse liver could accelerate hepatocyte proliferation by leading to rapid S-phase entry of hepatocytes during liver regeneration [14, 15] . Given the reported effect of miR221 on development and growth, it is proposed that miR221 might function in human embryo development. However, little is known about the function of miR221 in the human embryo.
Development of human placenta, which allows fetal-maternal exchanges during gestation, is critical for embryonic development. It is composed of a vascular network and stroma coming from the embryonic mesoderm, and of trophoblast cells that arise from the extra-embryonic tissue, and differentiate to achieve specialized functions [16] [17] [18] [19] [20] [21] . In the current study, we examined the miR221 expression in human placental tissue and analyzed the relationship between miR221 and its targeting genes.
Materials and Methods

Tissue collection
Human placentas tissue samples (n=29) were collected from the healthy pregnant women who were willing to terminate their pregnancy by vacuum aspiration at the PLA 458th hospital (Guangzhou, China), approved by local ethics committee of the hospital. Informed consent for the experimental use of the surgically removed samples was obtained at 5-10 weeks after their last menstrual period. Gestational age was determined based on the last menstrual period and by standard obstetric ultrasonography. At the time of the surgical procedure of abortion, the deciduas were separated from any products of conception under a dissecting microscope. First, the tissue samples were washed thoroughly with sterile normal saline to remove excess blood, mucous and fetal tissues. Then, fragments of decidua and deciduas with attached chorionic villi were transferred to a Petri dish with sterile normal saline which were examined under a dissecting microscope. The deciduas carefully dissected out from the branching chorionic villi were immediately kept in RNA-latter (Invitrogen, Carlsbad, CA) at -80°C for qRT-PCR.
Total RNA isolation, primers, and quantitative real-time PCR
The samples were pulverized in liquid nitrogen and then thoroughly homogenized in 1 mL TRizol Reagent (Invitrogen, USA) per 100 mg sample. The total RNA was extracted according to the manufacturer's instructions. The concentration of extracted RNA was determined by a spectrophotometer (BioPhotometer, Eppendorf, Germany). First-strand cDNA was reversely transcribed using 2 μg of total RNA in a total volume of 20 μL extracts according to the manufacturer's protocol of PrimerScript RT reagent Kit (Takara, Japan).
Each PCR reaction was performed with 2 μL of the cDNA and 0.2 μmol/L of each primer in a Light-Cycler System with SsoAdvancedTM SYBR Green Supermix (Bio-Rad, USA). Briefly, the RT-PCR reactions were run at 95°C for 10 min, followed by 40 cycles of 15 sec at 95°C and 20 sec at 60°C in the CFX96 realtime system (Bio-Rad). Each sample was assayed in triplicate and the primer sequences, and PCR conditions were listed in Table 1 . Preliminary experiments were performed with each pair of primers. Formation of the expected single product was ascertained in each reaction by melt curve analysis (starting from 72°C to 
microRNA reverse transcription and quantification
For the quantification of mature microRNAs, reverse transcription was performed using TaqMan MicroRNA Reverse Transcription Kit (Applied Biosystems, USA) with specific primer according to the manufacturer's protocol, and the products were stored at -20°C. The diluted total RNA (2 ng/μL, 5 μL) was reverse-transcribed by a total volume reaction of 3 μL RT primer and 7 μL RT master in an RNase free PCR tube, and then was mixed gently. The reaction was performed in a thermal cycler (Bio-Rad) at 16°C for 30 min, 42°C for 30 min, and 85°C for 5 min. miRNA-221 expression was measured by qRT-PCR using TaqMan MicroRNA Assay Kit (Applied Biosystems) according to the manufacturer's instructions. In briefly, 1.33 μL of cDNA was added to a final 20 µL volume of qRT-PCR reaction, which contained 1 μL TaqMan MicroRNA Assay, 10 μL Universal PCR Master Mix, and 7.67 μL Nuclease-free water. The reaction was performed using a CFX96 real-time system (Bio-Rad) at 95°C for 10 min, 40 cycles at 95°C for 15 sec and 60°C for 60 sec. The target transcript levels were normalized against the internal control GAPDH's expression.
Statistical analysis
The statistical difference between two groups was calculated using the nonparametric Mann-Whitney U test. The nonparametric Spearman correlation test was used to analyze the correlation of qRT-PCR data. A P<0.05 was considered to be statistically significant.
Results
miR221 expression level during normal pregnancy
To analyze the role of miR221 in human placental tissue, qRT-PCR was performed to investigate the miR221 expression pattern in placental tissue at a gestational age of 39 to 71 days. The results showed that miR221 had a low-level expression in 38-to 54-day placenta tissue, and it began to increase at day 55. miR221 expression was higher in 55-to 71-day placenta tissue (mean value=0.1049) than that in 38-to 54-day placenta tissue (mean value=0.0133) (p<0.001) ( Fig. 1) . The mRNA levels of the reported target genes of miR122 and their correlation in human placenta tissue It was reported that miR221 could target PI3K, DDIT4, CDKN1B, CDKN1C and FOS [22] [23] [24] [25] [26] [27] , resulting in down-regulating these genes. Moreover, these genes have an important role in embryo development ( Table 2) .
To investigate the association between miR221 and these reported target genes in human placental development, the expression level of the reported target genes and their correlation with miR221 were analyzed. PI3KR was expressed during the placenta development, but no statistical difference was observed between 38-to 54-day (mean value=0.0203) and 55-to 71-day (mean value=0.0283) samples (p>0.05). Further correlation analysis showed that PI3K expression was not correlated with miR221 expression (r=0.322, p=0.089) (Fig. 2) . The expression of DDIT4 was decreased in older-age placenta tissues (mean value: 0.0101 for 38~54 days, 0.0021 for 55~71 days, p<0.001), and was negatively correlated with miR221 expression (r=-0.396, p=0.033) (Fig. 3 ). CDKN1B was detected in the placenta tissues (mean value: 0.0298 for 38~54 days, 0.0378 for 55~71 days, p>0.05), but no statistically significant association of CDKN1B with miR221 was observed (r=0.298, p=0.128) (Fig. 4 ). CDKN1C was detected during the placenta development (mean value: 0.0582 for 38~54 days, 0.0847 for 55~71 days, p>0.05), with no statistically significant association between CDKN1C and miR221 expression (r=0.198, p=0.304) (Fig. 5 ). FOS was also discovered during the placenta development (mean value: 0.0298 for 38~54 days, 0.0303 for 55~71 days, p>0.05), and its expression was not significantly correlated with miR221 (r=0.171, p=0.347) (Fig. 6 ). MicroRNA is reported important in fetal growth restriction, pregnancy-related complications and preeclampsia, suggesting that it might play an important role in embryo development and could serve as a potential diagnostic marker for abnormal embryonic development [37] [38] [39] . miR221 is an important gene involved in development and growth [12] [13] [14] , however, the function of miR221 in human embryo development remains unclear. Given that the development of the human placenta is critical for embryonic development [16] [17] [18] [19] , we focus on the role of miR221 in human placental tissues. Our study shows that miR221 was increased during human placental development. The expression of miR221 was low in 38-to 54-day placenta and began to increase at day 55. Further analysis showed that the level of miR221 expression in 55-to 71-day placenta was higher than in 38-to 54-day placenta (mean value: 0.0133 at 38~54 days, 0.1049 at 55~71 days, p<0.001), suggesting that the increased expression of miR221 may be age-dependent. miR221 was expressed at low level at week 5, week 6, and week 7 of gestational age. At week 5, the nervous system including the brain and spinal cord, heart, and gastrointestinal tract begins to develop. At week 6~7 of gestational age, the arm and leg buds become visible, the brain develops into five areas and some cranial nerves are visible. The heart continues to develop and beat at a regular rhythm. Rudimentary blood moves through the main vessels [40] . Then, the expression of miR221 began to increase at the week 8, at which time the arms and legs grow longer, and foot and hand areas can be distinguished. The brain continues to form, and the lungs begin to form [40] . However, in the zebrafish embryo, miR-221 is expressed in neurons and/or cranial ganglia in forebrain and midbrain, as well as rhombomere, suggesting that miR221 has different functions in different species.
Accumulating data report the identification of aberrantly expressed miRNAs. Gene target prediction models and recent functional studies support the concept that miRNAs might impact the genesis and progression of diseases [41, 42] . Thus, we focus on a series gene related to embryo development targeting by miR221, and examine the association between miR221 and some of target genes in human placental development. Our results revealed that enhanced miR221 expression was negatively correlated with DDIT4, but not CDKN1B, CDKN1C, FOS, and PIK3R1. DDIT4 is an important gene for embryo development. Knockdown of DDIT4 could accelerate cell cycle exit by neuro-progenitors and their differentiation into neurons, and disrupt the migration of rat newborn neurons to the cortical plate resulting in the ectopic localization of mature neurons. On the other hand, over-expression of DDIT4 could delay neuronal differentiation, suggesting its essential role in the temporal control of cortical development and in cortical patterning [32] . DDIT4 expression parallels that of p63 in some ectoderm-derived tissues [43] . In our study, DDIT4 was highly expressed in the early stage of placenta development (38~54 days), in which the nervous system is developing rapidly and begins to have specific functions [40] . These data suggest that DDIT4 has an essential role in nervous system development of the human embryo. Moreover, 
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Cellular Physiology and Biochemistry DDIT4 expression was significantly decreased in older-age placenta tissues (55~71 days), which might be regulated by miR221. DDIT4 could inhibit mTOR signaling by regulating the mTOR substrate phosphorylation [31] . Thus, decreasing expression of DDIT4 tissues might result in mTOR signaling enhancing in human placenta. mTOR signaling is essential for the development of both embryonic and extraembryonic tissue, and its inactivation leads to early post-implantation lethality [44, 45] . Taken together, it is supposed that miR221 may play important role in placental development by precisely controlling the expression timing of DDIT4, in which the mTOR signaling pathway was also regulated.
Conclusion
In summary, we have shown that miR221 is up-regulated during human placental development. DDIT4, the reported target gene of miR221, was down-regulated in human placenta tissue. miR221 expression is negatively correlated with DDIT4 expression. miR221 may play an important role in human placental development by precisely regulating the DDIT4 expression, which serves as a switch of the mTOR signaling pathway.
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